Search Results - "Schladt, David S."

Multigene predictors of tacrolimus exposure in kidney transplant recipients by Pulk, Rebecca A, Schladt, David S, Oetting, William S, Guan, Weihua, Israni, Ajay K, Matas, Arthur J, Remmel, Rory P, Jacobson, Pamala A

“…Determine the effect of the genetic variants beyond CYP3A5*3 on tacrolimus disposition. We studied genetic correlates of tacrolimus trough concentrations with…”
Get full text

Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers by Reininger, Kevin A., Onyeaghala, Guillaume, Anderson‐Haag, Teresa, Schladt, David S., Wu, Baolin, Guan, Weihua, Dorr, Casey R., Remmel, Rory P., Mannon, Roslyn, Matas, Arthur J., Oetting, William S., Stahler, Paul, Israni, Ajay K., Jacobson, Pamala A.

“…Kidney transplant recipients carrying the CYP3A5*1 allele have lower tacrolimus troughs, and higher dose requirements compared to those with the CYP3A5*3/*3…”
Get full text

Development of a Patient-specific Search of Transplant Program Outcomes and Characteristics: Feedback From Kidney Transplant Patients by McKinney, Warren T., Schaffhausen, Cory R., Bruin, Marilyn J., Chu, Sauman, Schladt, David, Matas, Arthur, Snyder, Jon, Kasiske, Bertram, Israni, Ajay K.

“…Patients face obstacles in finding a transplant program that meets their healthcare needs. Acceptance criteria and waiting times vary by region and program…”
Get full text